Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Darren Hargrave
MEK Inhibition Appears to Improve Symptom Control in Primary NRAS-driven CNS Melanoma in Children
British Journal of Cancer
Cancer Research
Oncology
Integrated Analysis of Long-Term Growth and Bone Development in Pediatric and Adolescent Patients Receiving Bevacizumab
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Related publications
MEK-Inhibition Beim Inoperablen NRAS-mutierten Melanom
hautnah dermatologie
GAB2 Induces Tumor Angiogenesis in NRAS-driven Melanoma
Oncogene
Cancer Research
Genetics
Molecular Biology
645 MIG6 Is MEK-regulated and Affects EGF-induced Migration in Mutant NRAS Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma
Cancer Discovery
Oncology
A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS Mutant Melanoma
Cancer Research
Cancer Research
Oncology
P2.13-33 a Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient With NRAS Mutation Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
JAK Inhibition and Symptom Control in Myeloproliferative Neoplasms
Current Medical Research and Opinion
Medicine
Autophagy Modulation in MEK Inhibitor-Resistant Melanoma
British Journal of Dermatology
Dermatology
Medicine
Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers
Nature
Multidisciplinary